Grassi, Silvarosa, Ermelinda Francescangeli, Gianfrancesco anism, as mGluRs are greatly implied in increasing the gluta-Goracci, and Vito E. Pettorossi. Role of platelet-activating factor mate release (Pin and Duvoisin 1995) . The possible exisin long-term potentiation of the rat medial vestibular nuclei. J. tence of presynaptic mechanisms at vestibular level leads us Neurophysiol. 79: 3266-3271, 1998. In rat brain stem slices, we to ascertain whether mediators, which are reported to play a investigated the role of platelet activating factor (PAF) in longrole in coupling the postsynaptic and presynaptic phenomena term potentiation (LTP) induced in the ventral part of the medial (Davis and Murphey 1994; Medina and Izquierdo 1995; vestibular nuclei (MVN) by high-frequency stimulation (HFS) of Williams et al. 1993) , are involved in the vestibular LTP.
the primary vestibular afferent. The synaptosomal PAF receptor In particular, it has been demonstrated that platelet activatantagonist, BN-52021 was administered before and after HFS. BNing factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phospho-52021 did not modify the vestibular potentials under basal conditions, but it reduced the magnitude of potentiation induced by HFS, choline), is involved in the induction of LTP in the hippowhich completely developed after the drug wash-out. The same campus as a retrograde messenger, which mediates the glutaeffect was obtained by using CV-62091, a more potent PAF antagomate increase accompanying LTP (Clark et al. 1992 ; Kato nist at microsomal binding sites, but with concentrations higher Kornecki et al. 1996; Wierasko et al. 1993) . than those of BN-52021. By contrast both BN-52021 and CV-6209 In fact, PAF receptor antagonist, BN-52021, prevents LTP had no effect on the potentiation once induced. This demonstrates induction (Arai and Lynch 1992; Kato et al. 1994 ) and that PAF is involved in the induction but not in the maintenance application of carbamyl-PAF (c-PAF), a nonhydrolyzable of vestibular long-term effect through activation of synaptosomal PAF analogue, induces LTP (Izquierdo et al. 1995; Kato PAF receptors. In addition, we analyzed the effect of the PAF Packard et al. 1996; Wierasko et al. 1993 ).
analogue, 1-O-hexadecyl-2-O-(methylcarbamyl)-sn-glycero-3-Furthermore, BN-52021 has been reported recently to affect phosphocoline (MC-PAF) and the inactive PAF metabolite, 1-Ohexadecyl-sn-glycero-3-phosphocoline (Lyso-PAF) on vestibular the firing rate of MVN neurons (Maclennan et al. 1996) , responses. Our results show that MC-PAF, but not Lyso-PAF insuggesting the existence of PAF receptors at this level. duced potentiation. This potentiation was prevented by D,L-2-In the present study, we investigated whether PAF might amino 5-phosphonopentanoic acid, suggesting an involvement of play a role in vestibular LTP. Toward this aim we analyzed N-methyl-D-aspartate receptors. Furthermore, under BN-52021 and the effect of PAF receptor blockade on the induction and CV-6209, the MC-PAF potentiation was reduced or abolished. The maintenance of HFS-LTP and the possibility of inducing dose-effect curve of MC-PAF showed a shift to the right greater LTP by exogenous PAF administration.
under BN-52021 than under CV-6209, confirming the main dependence of MC-PAF potentiation on the activation of synaptosomal M E T H O D S PAF receptors. Our results suggest that PAF can be released in the MVN after the activation of postsynaptic mechanisms triggering Brain stem slices (400-500 mm), obtained from 34 Wistar rats LTP, and it may act as a retrograde messenger which activates the (150-250 g), were prepared and maintained as reported previously presynaptic mechanisms facilitating synaptic plasticity. (Capocchi et al. 1992; Grassi et al. 1995) . The field potentials (86 cases) and the unitary potentials (5 cases), evoked by vestibular afferent stimulation, were recorded
in the ventral portion (Vp) of MVN ( Fig. 1) , with 2 M sodium chloride-filled micropipettes (3-10 MV). The recorded field po-In rat brain stem slices, long-term potentiation (LTP) can tentials consisted of two waves: a positive-wave, representing the be induced in the medial vestibular nuclei (MVN) by highprimary vestibular fiber activation, and a negative wave (N1), frequency stimulation (HFS) of the primary vestibular afferrepresenting the monosynaptic activation of the secondary vestibular neurons (Fig. 1) . A second polysynaptic negative wave (N2), ents, through the activation of postsynaptic glutamate was observed rarely in our recording sites.
NMDA receptors (Capocchi et al. 1992; Grassi et al. 1996) .
The postsynaptic nature of the N1 wave was verified by a 3-ms It has been shown that in the hippocampus LTP is triggered interval paired-pulse test, which only caused the disappearance of postsynaptically, but its expression may depend on a presynthe N1 wave (Fig. 1) , and by using a Ca 2/ -free solution (Grassi et aptic increase of transmitter release (Bliss and Collingridge al. 1996) (Fig. 1 ). All recordings were amplified, filtered with a 1993; Bliss et al. 1986 ). We suggest that presynaptic mechawideband filter (0-10 kHz) and stored in a computer (486) nisms also might be involved in vestibular LTP. Our recent equipped with a data acquisition card (AT-MIO-16E-2, National finding showing that the expression of this potentiation re-Instruments, Austin, TX). In most experiments, bipolar NiCr stimuquires the activation of metabotropic glutamate receptors lating electrodes were placed at the point where the vestibular afferents enter the MVN (Fig. 1) . Stimulus test parameters were 40-to (mGluRs) (Grassi et al. 1997 ) supports a presynaptic mech-FIG . 1. Recording sites (q) in the ventral portion of the medial vestibular nuclei (MVN) and medial and lateral stimulating zones (shaded areas) are plotted on the diagrams of 0.5-mm-spaced brain stem slices. Right, top: field potential recorded in normal and Ca 2/free solution; bottom: single pulse response is superimposed onto a 3-ms paired-pulse stimulation to show how the first negative wave (N1) peak negative voltage was calculated compared with baseline (vertical line). D, descending vestibular nucleus; Md, Mv, medial vestibular nucleus: dorsal and ventral portions; L, lateral vestibular nucleus; S, superior vestibular nucleus. 100-mA intensity, 0.07-ms duration, and 0.06-Hz frequency. HFS by the electrical stimulus decay (Fig. 1) and by measuring the peak latency of evoked unitary potentials. consisted of four bursts at 100 Hz applied with alternated polarity for 2 s with a 5-s interval. Moreover, to avoid possible activation To show the time course of the effects, the wave amplitudes were measured every 15 s and expressed as a percentage of the of fibers mediating internuclear interactions and to restrict stimulation to vestibular afferents only, in 14 slices, we stimulated the baseline (the mean of the 1st 20 responses). To compare the effects within a single experiment and among different ones, we consid-vestibular root before entering the vestibular nuclear complex (Fig.  1 ). We pooled together the data from both stimulation zones, as no ered the average value within a 5-min interval at the steady state of each experimental condition. Statistical significance was evaluated different results were obtained. The localization of recording and stimulating sites was verified by histological analysis.
using paired t-tests and established at P õ 0.05. We used two PAF receptor antagonists, ginkgolide B (BN-52021, Biomol, Plymouth, PA; 0.5-2 mM), a potent inhibitor of R E S U L T S synaptosomal binding sites and CV-6209 (Biomol; 0.5-2 mM), which is a more potent antagonist for microsomal binding sites Effect of BN-52021 on the induction and maintenance of (Marcheselli et al. 1990 ). We also used the NMDA receptor antag-HFS-LTP in the MVN onist, D,L-2-amino 5-phosphonopentanoic acid (AP-5, Sigma, St. Louis, MO; 100 mM), the nonhydrolyzable PAF analogue, 1-O-BN-52021 (0.5-2 mM) did not modify the amplitude of hexadecyl -2 -O -(methylcarbamyl) -sn -glycero -3 -phosphocoline field potentials under basal conditions, and under drug infu-(MC-PAF, Cayman Chemical, Ann Arbor, MI; 0.004-1 mM), and sion, HFS could still enhance the N1 wave with the same the inactive PAF metabolite, 1-O-hexadecyl-sn-glycero-3-phosfrequency (71% of the examined cases) as that after HFS phocoline (Lyso-PAF, Biomol; 0.1 mM). Stock solution of BNalone (see Grassi et al. 1996) . However, the magnitude of 52021 (1 mM) was dissolved in 25% dimethylsulfoxide (DMSO) potentiation was significantly reduced (114.03 { 2.34%, and that of MC-PAF (1 mM) in a buffer containing bovine serum mean { SD; n Å 7, Fig. 2, A, C, and D) , compared with albumin. Working drug solutions were prepared freshly in artificial that induced by HFS alone (135.34 { 5.22%, Fig. 2, B- cerebrospinal fluid and perfused at a rate of 2 ml/min. D). We pooled together the data from different BN-52021
We analyzed the influence of HFS and drug application by meaconcentrations, as no different reduction values were obsuring the amplitude of the field potential N1 wave as the difference between the wave peak negative voltage and a baseline influenced tained. Interestingly, after the drug wash-out, the potentiation 9K29
J628-7RC / 9k28$$my14 05-18-98 14:43:02 neupa LP-Neurophys experiments in which BN-52021 (ᮀ, n Å 7 before HFS, n Å 5 after HFS), DMSO (ø, n Å 4 before HFS) and CV-6209 (, n Å 4 before HFS, n Å 3 after HFS) were given. Drugs given before HFS: Drug, drug infusion; Drug / HFS, HFS under drugs; Drug wo, drug wash-out after HFS; HFS / wo, HFS given again after drug wash-out. Drugs given after HFS: HFS / Drug, drugs after HFS; HFS, HFS alone (). *P õ 0.05, significantly different from all the other values. D: averaged field potentials (10 sweeps). Left: before (control) and after HFS alone; right: before (control), after HFS under BN-52021 and after BN-52021 wash-out. fully developed to reach 136.88 { 6.66% (n Å 7; Fig. 2 , A, ment of HFS potentiation. No significant change in the N1 wave was observed after drug infusion (Fig. 2, B and C) . C, and D), and HFS applied again did not further enhance it. In contrast, under CV-6209 (0.5 and 1 mM), HFS induced Effect of MC-PAF on the field potentials in the MVN a full potentiation (134.56 { 6.54, n Å 4, Fig. 2C ). Only 2 mM CV-6209 could affect the potentiation, which was MC-PAF at different concentrations induced a potentiareduced (122.23 { 1.56%, n Å 3) when HFS was applied tion of the N1 wave. Although 0.004, 0.005, and 0.006 mM under the drug and enhanced to 135.56 { 3.22%, n Å 3, MC-PAF (3 cases) could not provoke any effect, the potentiafter the drug wash-out. ation could be induced by using MC-PAF at 0.008 mM As it has been reported that DMSO can influence the firing (120.19 { 6.87%, n Å 4) ( Fig. 3B) . Higher potentiation rate of MVN neuron (Maclennan et al. 1996) , we tested the values (Ç140%) were obtained by using MC-PAF at 0.01 effect of this substance (DMSO 0.05%, 4 cases), given (4 cases) and 0.05 mM (3 cases), whereas lower ones alone, on the induction of LTP. In this condition, HFS in-(Ç122%) were obtained at 0.1 (4 cases), 0.5 (3 cases), duced a full potentiation of the N1 wave (133.66 { 5.08%, and 1 mM (4 cases) (Fig. 3B) . The MC-PAF enhancement n Å 4), which remained at the same level at DMSO washof N1 began 3-5 min after the drug application, it reached out (Fig. 2C) .
the steady state Ç10 min after, and persisted after wash-out The possible effect on the maintenance of the N1 potentiathroughout the recording period (ú60 min; Fig. 3A ). HFS tion of PAF receptor block was assayed by administering applied when this potentiation was established did not enhance it (Fig. 3, A and B) . BN-52021 (2 mM) and CV-6209 (2 mM) after the establish-
9K29
J628-7RC / 9k28$$my14 05-18-98 14:43:02 neupa LP-Neurophys under Lyso-PAF (0.1 mM, n Å 5), and MC-PAF (0.006 mM, n Å 3; 0.008 mM, n Å 4; 0.01 mM, n Å 4; 0.05 mM, n Å 3; 0.1 mM, n Å 4; 0.5 mM, n Å 3; and 1 mM, n Å 4). Drug effects were compared with those induced by HFS after drug wash-out in each experimental condition. *, significant differences ( P õ 0.05) between the drug and HFS effects. C: time course of the effects of MC-PAF administered during and after D,L-2-amino 5-phosphonopentanoic acid (AP-5; ᭺ and ᮀ ) and BN-52021 (q and ) infusion, in 2 experiments. D: effect of MC-PAF on the peak latency of evoked unitary potentials (10 superimposed traces). Dotted lines indicate the peak latency shift (mean values). Note the latency reduction and the appearance of doublet discharge after MC-PAF.
MC-PAF (0.05 mM) effect was prevented completely by drug wash-out. The vehicle alone (DMSO, 0.05%) could not prevent the MC-PAF potentiation (3 cases). AP-5 (4 cases), whereas MC-PAF induced potentiation only after AP-5 wash-out (n Å 4; Fig. 3C ). In addition, the inac-
The dose-effect curve of the MC-PAF also was analyzed under infusion of BN-52021 and CV-6209 at different con-tive PAF metabolite, Lyso-PAF (4 cases) was quite ineffective (Fig. 3, A and B) , and the following HFS could induce centrations. As shown in Fig. 4, BN-52021 showed a more potent blocking effect on MC-PAF potentiation than CV-a clear potentiation (Fig. 3B) .
We also examined the effect of MC-PAF (0.05 mM) on 6209, as 1 mM BN-52021 prevented the potentiation induced by 0.008 and 0.010 mM PAF, whereas CV-6209 was effec-the unitary activity elicited in Vp. The peak latency of evoked unitary potentials ranged from 1.2 to 2 ms, and it tive only at 2 mM. On the whole, the dose-effect curve showed a shift to the right greater under BN-52021 than significantly decreased by Ç0.2 { 0.03 ms (n Å 5) after MC-PAF infusion throughout the recording period (ú40 under CV-6209. This result suggests the main dependence of MC-PAF potentiation on the activation of synaptosomal min; Fig. 3D ).
PAF receptors.
Effect of BN-52021 and CV-6209 on the MC-PAF potentiation D I S C U S S I O N
In this study, we have shown that PAF plays a role in the N1 wave potentiation by MC-PAF (0.05 mM) was prevented by infusion of BN-52021 (2 mM) (4 cases), and it NMDA-dependent LTP taking place in the MVN after HFS of the primary vestibular afferents (Capocchi et al. 1992 ; was induced (135.22 { 5.22%, n Å 4; Fig. 3C) ) and CV-6209 ( ---) on the enhancement of N1 wave induced by different concentrations of MC-PAF. Each point represents the mean (n Å 3 or 4) and SD (expressed as a percentage of the baseline). Grassi et al. 1996) . In fact, BN-52021, a potent PAF compet-mate release (Bazan and Allan 1996; Bito et al. 1992; Clark et al. 1992; Kato et al. 1994; Wieraszko et al. 1993 ). Our itive antagonist for synaptosomal binding sites (Marcheselli et al. 1990) , reduced, at low concentrations, the magnitude results showing the reduction of HFS potentiation under PAF competitive antagonists and its full development after drug of potentiation induced by HFS. The same effect could be obtained by using CV-6209, which is a more potent antago-wash-out, together with the fact that the PAF interaction seems to occur at presynaptic level, appear to be consistent nist at microsomal receptors (Marcheselli et al. 1990 ), but with concentrations four times higher than those of BN-with a role of the PAF as a retrograde messenger. In fact, a block of the retrograde messenger receptors would reduce 52021. Conversely, PAF receptor activation does not seem to be necessary for LTP maintenance, as both BN-52021 the amplitude of the potentiation, which still could be induced at the postsynaptic level. At the removal of receptor and CV-6209 did not affect potentiation, once induced. Moreover, further evidence to support the involvement of block, the PAF, synthesised following the already activated postsynaptic events, would lead to the full LTP induction. PAF in vestibular synaptic plasticity, has been attained by using MC-PAF. In fact, MC-PAF was capable of inducing
In conclusion, our results suggest that PAF could be involved in facilitating LTP induction in the MVN after the LTP in the MVN independently of HFS. The full block of MC-PAF dependent LTP by NMDA antagonist, suggests HFS activation of postsynaptic NMDA receptors. It might act as a retrograde messenger that activates the presynaptic that this potentiation is the result of a presynaptic action of MC-PAF leading to an increase of glutamate release, which mechanisms enhancing the glutamate release. activates NMDA receptors. The fact that HFS could not induce further potentiation indicates that HFS-LTP and PAF-
